本頁面由Tiger Trade Technology Pte. Ltd.提供服務

TELA Bio, Inc.

1.07
+0.03002.88%
成交量:24.25萬
成交額:25.06萬
市值:4,830.34萬
市盈率:-1.38
高:1.10
開:1.03
低:0.9696
收:1.04
52周最高:1.69
52周最低:0.5011
股本:4,514.34萬
流通股本:2,151.90萬
量比:1.91
換手率:1.13%
股息:- -
股息率:- -
每股收益(TTM):-0.7776
每股收益(LYR):-0.8300
淨資產收益率:-616.62%
總資產收益率:-33.40%
市淨率:-3.04
市盈率(LYR):-1.29

資料載入中...

2026/08/31

重要事件披露

Form 8-K - Current report
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

重要事件披露

Form 8-K/A - Current report: [Amend]
2026/08/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/11

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/10

重要事件披露

Form 8-K - Current report
2026/08/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/04

重要事件披露

Form 8-K - Current report
2026/06/11

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

重要事件披露

Form 8-K - Current report
2026/04/30

重要事件披露

Form 8-K - Current report
2026/03/25

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/25

重要事件披露

Form 8-K - Current report
2026/03/20

重要事件披露

Form 8-K - Current report
2025/12/17

SEC問詢函

Form CORRESP - Correspondence